These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 2197265)

  • 1. Chronic myelogenous leukemia with typical clinical and morphological features can be Philadelphia chromosome negative and "bcr negative".
    Selleri L; Emilia G; Luppi M; Temperani P; Zucchini P; Tagliafico E; Artusi T; Sarti M; Donelli A; Castoldi GL
    Hematol Pathol; 1990; 4(2):67-77. PubMed ID: 2197265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Demonstration of BCR-ABL rearrangement in a patient with apparently Ph-negative chronic myeloid leukemia of 15 years' duration].
    Valiente A; Outeriño J; Martín Calderín F; Benítez J
    Sangre (Barc); 1990 Dec; 35(6):481-3. PubMed ID: 2087668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The usefulness of the bcr/abl rearrangement in the diagnosis and evolution of chronic myeloid leukemia].
    González FA; Villegas A; Ferro MT; San Román C; Sáez I; López M; del Potro E; Alvarez A; Martínez R; Díaz Madiavilla J
    Med Clin (Barc); 1993 Oct; 101(14):521-4. PubMed ID: 8231395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cytogenetic and molecular studies in patients with chronic myelogenous leukemia without Ph chromosome and with unusual Ph translocation].
    Xue YQ
    Zhonghua Yi Xue Za Zhi; 1993 Apr; 73(4):209-12, 252-3. PubMed ID: 8395313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Molecular study of Ph1 chromosome negative chronic myelocytic leukemia].
    Chen S
    Zhonghua Yi Xue Za Zhi; 1991 Aug; 71(8):425-7, 30. PubMed ID: 1660759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complex chromosome rearrangements may locate the bcr/abl fusion gene sites other than 22q11.
    Sessarego M; Fugazza G; Bruzzone R; Ballestrero A; Miglino M; Bacigalupo A
    Haematologica; 2000 Jan; 85(1):35-9. PubMed ID: 10629589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics and outcome of patients with Philadelphia chromosome negative, bcr/abl negative chronic myelogenous leukemia.
    Onida F; Ball G; Kantarjian HM; Smith TL; Glassman A; Albitar M; Scappini B; Rios MB; Keating MJ; Beran M
    Cancer; 2002 Oct; 95(8):1673-84. PubMed ID: 12365015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abnormal chromatin clumping in granulocytes in a case of Ph1-negative, BCR-ABL rearrangement positive, haematologically atypical chronic myeloid leukaemia (CML).
    Tertian G; Misrahi M; Diallo D; Mielot F; Leonard C; Salmeron S; Tchernia G
    Nouv Rev Fr Hematol (1978); 1995; 37(4):245-7. PubMed ID: 8904205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The bcr gene is joined to c-abl in Ph1 chromosome negative chronic myelogenous leukemia.
    Dreazen O; Klisak I; Rassool F; Goldman JM; Sparkes RS; Gale RP
    Oncogene Res; 1988; 2(2):167-75. PubMed ID: 3217110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BCR/ABL rearrangement in two cases of Philadelphia chromosome negative chronic myeloid leukemia: deletion on the derivative chromosome 9 may or not be present.
    Batista DA; Hawkins A; Murphy KM; Griffin CA
    Cancer Genet Cytogenet; 2005 Dec; 163(2):164-7. PubMed ID: 16337861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute lymphoid leukemia molecular phenotype in a patient with benign-phase chronic myelogenous leukemia.
    Guo JQ; Hirsch-Ginsberg CF; Xian YM; Stass SA; Champlin RE; Giralt SA; McCredie KB; Campbell ML; Arlinghaus RB
    Hematol Pathol; 1993; 7(2):91-106. PubMed ID: 8340287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Molecular analysis of chronic Philadelphia chromosome negative myeloid leukemia: study of 6 cases].
    Cervantes F; Urbano-Ispizua A; Pujades A; Bosch F; Vives-Corrons JL; Montserrat E; Rozman C
    Med Clin (Barc); 1992 Sep; 99(8):286-8. PubMed ID: 1453821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Philadelphia chromosome-negative chronic myelogenous leukemia without breakpoint cluster region rearrangement: a chronic myeloid leukemia with a distinct clinical course.
    Kurzrock R; Kantarjian HM; Shtalrid M; Gutterman JU; Talpaz M
    Blood; 1990 Jan; 75(2):445-52. PubMed ID: 2403827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic myelogenous leukemia with the e6a2 BCR-ABL and lacking imatinib response: presentation of two cases.
    Vefring HK; Gruber FX; Wee L; Hovland R; Hjorth-Hansen H; Gedde Dahl T; Meyer P
    Acta Haematol; 2009; 122(1):11-6. PubMed ID: 19641300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Absence in Ph-negative, M-BCR rearrangement-positive chronic myelogenous leukemia of linkage between 5' ABL and 3' M-BCR sequences in Philadelphia translocation.
    Nishigaki H; Misawa S; Inazawa J; Abe T
    Leukemia; 1992 May; 6(5):385-92. PubMed ID: 1593904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unique secondary chromosomal abnormalities are frequently found in the chronic phase of chronic myeloid leukemia in southern Vietnam.
    Phan TX; Hoang AV; Huynh VM; Nguyen KT; Nguyen TB; Huynh N; Pham QT; Tran VB; Tran VB; Tokunaga K; Sato Y
    Cancer Genet Cytogenet; 2006 Jul; 168(1):59-68. PubMed ID: 16772122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p190 bcr-abl rearrangement: a secondary cytogenetic event in some chronic myeloid disorders?
    Roumier C; Daudignon A; Soenen V; Dupriez B; Wetterwald M; Lai JL; Cosson A; Fenaux P; Preudhomme C
    Haematologica; 1999 Dec; 84(12):1075-80. PubMed ID: 10586207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical, morphological, cytogenetic and molecular aspects of a series of Ph-negative chronic myeloid leukemias.
    Aurich J; Duchayne E; Huguet-Rigal F; Bauduer F; Navarro M; Perel Y; Pris J; Caballin MR; Dastugue N
    Hematol Cell Ther; 1998 Aug; 40(4):149-58. PubMed ID: 9766919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical use of the bcr/abl probe test in the evaluation of chronic myeloid leukemia patients.
    Yazici H; Sengün Z; Aktan M; Aktuglu G; Uskent N; Dalay N
    J Exp Clin Cancer Res; 1997 Mar; 16(1):105-9. PubMed ID: 9148870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Breakpoint cluster region, immunoglobulin, and T-cell receptor gene rearrangement analysis in juvenile chronic myelogenous leukemia.
    Farhi DC; Luckey CN; Siddiqui AM
    Mod Pathol; 1995 May; 8(4):389-93. PubMed ID: 7567936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.